Pharmaceutical company Pfizer is building manufacturing capacity for vaccines in SA, but it will not manufacture a Covid-19 vaccine in the country.

Rhulani Nhlaniki, the cluster lead for Sub-Saharan Africa and country manager for SA at Pfizer, said this week that in SA the group is working with the Biovac Institute to manufacture the pneumococcal conjugate vaccine.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now